Decoding Antimicrobial Resistance: Unraveling Molecular Mechanisms and Targeted Strategies

Overview

Journal Arch Microbiol

Specialty Microbiology

Date 2024 May 28

PMID 38805035

Authors

Gagandeep Singh

Anita Rana

Smriti

Affiliations

Soon will be listed here.

Abstract

Antimicrobial resistance poses a significant global health threat, necessitating innovative approaches for combatting it. This review explores various mechanisms of antimicrobial resistance observed in various strains of bacteria. We examine various strategies, including antimicrobial peptides (AMPs), novel antimicrobial materials, drug delivery systems, vaccines, antibody therapies, and non-traditional antibiotic treatments. Through a comprehensive literature review, the efficacy and challenges of these strategies are evaluated. Findings reveal the potential of AMPs in combating resistance due to their unique mechanisms and lower propensity for resistance development. Additionally, novel drug delivery systems, such as nanoparticles, show promise in enhancing antibiotic efficacy and overcoming resistance mechanisms. Vaccines and antibody therapies offer preventive measures, although challenges exist in their development. Non-traditional antibiotic treatments, including CRISPR-Cas systems, present alternative approaches to combat resistance. Overall, this review underscores the importance of multifaceted strategies and coordinated global efforts to address antimicrobial resistance effectively.

Citing Articles

Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens.

Sakalauskiene G, Malciene L, Stankevicius E, Radzeviciene A Antibiotics (Basel). 2025; 14(1).

PMID: 39858349 PMC: 11762671. DOI: 10.3390/antibiotics14010063.

Community pharmacists' knowledge, beliefs, and perceived barriers toward vaccination services at community pharmacies: A cross-sectional study from Saudi Arabia.

Alrasheedy A, Alharbi A, Alturaifi H, Alkhamis R, Almazyad R, Almozaini S Hum Vaccin Immunother. 2024; 20(1):2414551.

PMID: 39693183 PMC: 11487963. DOI: 10.1080/21645515.2024.2414551.

Mechanism-guided strategies for combating antibiotic resistance.

Sun S, Chen X World J Microbiol Biotechnol. 2024; 40(10):295.

PMID: 39122871 DOI: 10.1007/s11274-024-04106-8.

References

Abd El-Aleam R, George R, Georgey H, Abdel-Rahman H . Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance. RSC Adv. 2022; 11(58):36459-36482. PMC: 9043591. DOI: 10.1039/d1ra06238g. View

Abo-Neima S, Motaweh H, Elsehly E . Antimicrobial activity of functionalised carbon nanotubes against pathogenic microorganisms. IET Nanobiotechnol. 2020; 14(6):457-464. PMC: 8676267. DOI: 10.1049/iet-nbt.2019.0342. View

Ali A, Anani H, Selim F . Biologically formed silver nanoparticles and study of their antimicrobial activities on resistant pathogens. Iran J Microbiol. 2022; 13(6):848-861. PMC: 8816695. DOI: 10.18502/ijm.v13i6.8090. View

Al-Saeedi M, Al-Hajoj S . Diversity and evolution of drug resistance mechanisms in . Infect Drug Resist. 2017; 10:333-342. PMC: 5648319. DOI: 10.2147/IDR.S144446. View

Andrade F, Silva D, Rodrigues A, Pina-Vaz C . Colistin Update on Its Mechanism of Action and Resistance, Present and Future Challenges. Microorganisms. 2020; 8(11). PMC: 7692639. DOI: 10.3390/microorganisms8111716. View

Andriole V . The quinolones: past, present, and future. Clin Infect Dis. 2005; 41 Suppl 2:S113-9. DOI: 10.1086/428051. View

Antimisiaris S, Marazioti A, Kannavou M, Natsaridis E, Gkartziou F, Kogkos G . Overcoming barriers by local drug delivery with liposomes. Adv Drug Deliv Rev. 2021; 174:53-86. DOI: 10.1016/j.addr.2021.01.019. View

Arsene M, Viktorovna P, Alla M, Mariya M, Davares A, Carime B . Antimicrobial activity of phytofabricated silver nanoparticles using L. against Gram-negative bacteria. Vet World. 2023; 16(6):1301-1311. PMC: 10421558. DOI: 10.14202/vetworld.2023.1301-1311. View

Arshia , Khan A, Khan K, Ahmed A, Taha M, Perveen S . Antibiofilm potential of synthetic 2-amino-5-chlorobenzophenone Schiff bases and its confirmation through fluorescence microscopy. Microb Pathog. 2017; 110:497-506. DOI: 10.1016/j.micpath.2017.07.040. View

10.

Bajaj P, Singh N, Virdi J . Escherichia coli β-Lactamases: What Really Matters. Front Microbiol. 2016; 7:417. PMC: 4811930. DOI: 10.3389/fmicb.2016.00417. View

11.

Banoee M, Seif S, E Nazari Z, Jafari-Fesharaki P, Shahverdi H, Moballegh A . ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli. J Biomed Mater Res B Appl Biomater. 2010; 93(2):557-61. DOI: 10.1002/jbm.b.31615. View

12.

Baquero F, Levin B . Proximate and ultimate causes of the bactericidal action of antibiotics. Nat Rev Microbiol. 2020; 19(2):123-132. PMC: 7537969. DOI: 10.1038/s41579-020-00443-1. View

13.

Barreto-Santamaria A, Arevalo-Pinzon G, Patarroyo M, Patarroyo M . How to Combat Gram-Negative Bacteria Using Antimicrobial Peptides: A Challenge or an Unattainable Goal?. Antibiotics (Basel). 2021; 10(12). PMC: 8698890. DOI: 10.3390/antibiotics10121499. View

14.

Bay D, Rommens K, Turner R . Small multidrug resistance proteins: a multidrug transporter family that continues to grow. Biochim Biophys Acta. 2007; 1778(9):1814-38. DOI: 10.1016/j.bbamem.2007.08.015. View

15.

Beceiro A, Tomas M, Bou G . Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clin Microbiol Rev. 2013; 26(2):185-230. PMC: 3623377. DOI: 10.1128/CMR.00059-12. View

16.

Bechinger B, Juhl D, Glattard E, Aisenbrey C . Revealing the Mechanisms of Synergistic Action of Two Magainin Antimicrobial Peptides. Front Med Technol. 2022; 2:615494. PMC: 8757784. DOI: 10.3389/fmedt.2020.615494. View

17.

Bevan E, Jones A, Hawkey P . Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017; 72(8):2145-2155. DOI: 10.1093/jac/dkx146. View

18.

Beyer D, Pepper K . The streptogramin antibiotics: update on their mechanism of action. Expert Opin Investig Drugs. 2005; 7(4):591-9. DOI: 10.1517/13543784.7.4.591. View

19.

Blair J, Webber M, Baylay A, Ogbolu D, Piddock L . Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2014; 13(1):42-51. DOI: 10.1038/nrmicro3380. View

20.

Blair J, Richmond G, Piddock L . Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 2014; 9(10):1165-77. DOI: 10.2217/fmb.14.66. View